Kimberlee Brontsema
Endocrinology, Diabetes & Metabolism · Scottsdale, AZNPI 1891786422
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 391 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 44 manufacturers, the largest accounting for just 20.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,512, 4.6 times the $552 reported in 2021.
Across 391 payments — averaging $21.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- Lilly USA, LLC$1K
- Dexcom, Inc.$797
- Corcept Therapeutics$486
- Radius Health, Inc.$410
- Amgen$360
- plus $3K from 38 others
What the payments were for
- Food & beverage$8,574100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozempic$686
- RYBELSUS$238
- Korlym$134
- Prolia$125
- JARDIANCE$124
- Kerendia$122
- Pogo Automatic Blood Glucose Monitoring System$120
- TOUJEO$102
- DEXCOM G7 GSS (161)$102
How this compares
$8,586 in reported general payments places this provider in the 75th percentile of 148 endocrinology, diabetes & metabolism providers in Arizona.
See all endocrinology, diabetes & metabolism providers in Arizona →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 286 | $484,156 |
| MounjaroTirzepatide | 143 | $182,022 |
| JardianceEmpagliflozin | 90 | $132,616 |
| Tresiba Flextouch U-200Insulin Degludec | 63 | $87,518 |
| TrulicityDulaglutide | 51 | $77,431 |
| Tresiba Flextouch U-100Insulin Degludec | 76 | $70,594 |
| RybelsusSemaglutide | 17 | $35,095 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 44 | $34,229 |
| Humalog Kwikpen U-100Insulin Lispro | 73 | $30,748 |
| Lyumjev Kwikpen U-100Insulin Lispro-Aabc | 23 | $25,055 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 13 | $15,527 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 71 | $12,783 |
| Novolog FlexpenInsulin Aspart | 48 | $12,241 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 88 | $9,864 |
| HumalogInsulin Lispro | 31 | $8,535 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $1,750 | $519,251303 claims |
| Lilly USA, LLCMounjaro, Trulicity, Humalog | $1,425 | $267,987225 claims |
| Boehringer IngelheimJardiance | $288 | $132,61690 claims |
| AbbVieSynthroid | $234 | $5,48071 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $209 | $3,345332 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 148 endocrinology, diabetes & metabolism providers in Arizona.
Other endocrinology, diabetes & metabolism in Scottsdale
- Amir HarariScottsdale$361K
- Kristina BlohmScottsdale$220K
- Andrea FerencziScottsdale$132K
- Sreedevi ReddyScottsdale$28K
- Grace Zlaket MattaScottsdale$17K
- Heather SaranScottsdale$14K
- Chandana MishraScottsdale$11K
- Vincent LiouScottsdale$10K
- Dena HaddadScottsdale$8K
- Mercedes RomeroScottsdale$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.